Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer

Keyphrases

• Meta-analysis 100%
• Radiotherapy 100%
• Prostate Cancer 100%
• Genome-wide Association Study 100%
• Late Toxicity 100%
• Genetic Markers 100%
• Confidence Interval 66%
• Odds Ratio 66%
• SNP 66%
• Cancer Patients 66%
• Urinary Frequency 66%
• Radiotherapy Toxicity 66%
• Kidney 33%
• Quality of Life 33%
• Single nucleotide Polymorphism 33%
• Risk Prediction 33%
• Fixed Effects 33%
• Patient Characteristics 33%
• Bladder 33%
• Genetic Variants 33%
• Cancer Risk 33%
• Small Intestine 33%
• Prostate Radiotherapy 33%
• Rectum 33%
• Rectal Bleeding 33%
• Long-term Cancer Survivors 33%
• Individual-level Data 33%
• Moderate Penetrance 33%
• Pelvic Radiotherapy 33%
• Toxicity Markers 33%
• Collaborative Efforts 33%
• Risk Profiling 33%
• Multivariable Regression 33%
• Polygenic Risk 33%
• Toxicity Endpoints 33%
• Limit Dose 33%

Medicine and Dentistry

• Radiation Therapy 100%
• Meta-Analysis 100%
• Prostate Cancer 100%
• Genome Wide Association Study 100%
• Genetic Marker 100%
• Malignant Neoplasm 60%
• Single Nucleotide Polymorphism 60%
• Urinary Frequency 40%
• Odds Ratio 40%
• Quality of Life 20%
• Penetrance 20%
• Side Effect 20%
• Bladder 20%
• Rectal Bleeding 20%
• Radiotherapy Prostate Cancer 20%
• Pelvic Radiotherapy 20%
• Small Intestine 20%

Biochemistry, Genetics and Molecular Biology

• Single Nucleotide Polymorphism 100%
• Genome-Wide Association Study 100%
• Urinary Frequency 100%
• Genetic Marker 100%
• Single-Nucleotide Polymorphism 50%
• Genetic Divergence 50%
• Penetrance 50%
• Small Intestine 50%